Proton Therapy Systems Market - By Set-up Type (Single Room, Multiple Room), By Indication (Breast Cancer, Lung Cancer, Prostate Cancer, Gastro-intestinal Cancer, Brain Cancer), By End-use (Hospitals, Proton Therapy Centers) – Global Forecast to 2032

Proton Therapy Systems Market Size

Proton Therapy Systems Market was valued at USD 1.2 billion in 2022 and is estimated to account for USD 3.2 billion by 2032.
 

Cancer is a major health concern worldwide, and its prevalence is increasing at an alarming rate. The World Cancer Research Fund International estimated that approximately 19 million new cancer cases were registered in 2021, and this number is anticipated to increase to 24 million by 2035, globally. Moreover, according to the American Cancer Society, around 1.9 million new cases of cancer were diagnosed in the U.S. alone in 2021. Thus, rise in the number of cancer cases is one of the major drivers of growth in the market.
 

The growing demand for non-invasive cancer treatment options is driving the growth of the proton therapy systems market. Proton therapy is a non-invasive treatment option that delivers high doses of radiation to cancer cells while minimizing damage to surrounding healthy tissues. This makes it a striking option for patients that want to avoid the side effects associated with traditional cancer treatments such as chemotherapy and surgery. Various other advantages associated with proton therapy systems, such as high precision and radiation control, reduced risk of side effects, and minimal exposure of normal tissues to radiation, make it the most suitable treatment option for pediatric cancer cases especially. Thus, these factors are considered as major factors leading the market industry.
 

COVID-19 Impact

The COVID-19 pandemic had a considerable impact on the proton therapy systems market, particularly in terms of hospital-based implementation and operational response. The proton therapy market relies on complex and specialized equipment, including cyclotrons and synchrotrons, which are essential for generating proton beams. The pandemic disrupted global supply chains, causing delays in the delivery and installation of these critical components, impacting the expansion of proton therapy centers and maintenance of existing ones.
 

Moreover, the economic repercussions of the pandemic affected healthcare budgets, including funding for proton therapy facilities. Numerous hospitals and institutions faced financial strain, leading to budget cuts and reconsideration of capital-intensive projects such as the construction of new proton therapy centers. However, there are opportunities for growth as the healthcare landscape continues to evolve. Increased awareness of health, the integration of telehealth, and ongoing research and innovation may contribute to the resilience and expansion of the proton therapy market in a post-pandemic world.
 

Proton Therapy Systems Market Trends

Cancer continues to be a major global health challenge, in 2020, there were an estimated 19 million new cancer cases reported worldwide. As per estimates the number of new cancer cases is anticipated to increase to 30 million per year by 2040. With millions of new cases diagnosed each year, advancements in cancer treatment are essential to improving patient outcomes. Proton therapy, an innovative and highly precise form of radiation therapy, has gained significant attention and popularity in recent years. As awareness of proton therapy's benefits spreads among patients, caregivers, and healthcare providers, more individuals are seeking this treatment option.
 

Media coverage and success stories have played a role in boosting awareness and demand. In some regions, patient demand for proton therapy has led to longer waiting times for treatment due to the limited number of available centers. Thus, the rising cases of cancer are driving an increased demand for proton therapy as an effective and targeted treatment option will contribute to industry landscape.
 

Proton Therapy Systems Set-up Market Analysis

The proton therapy systems market by set-up type is segregated into single room and multiple room. The single room segment is predicted to witness CAGR of 10.5% over the forecast period. Single-room proton therapy systems have gained popularity due to their ability to treat a wide range of cancer types effectively. They offer advanced treatment options for tumors located in sensitive areas, where precision is critical, such as brain, head and neck, breast, lung, and prostate cancers. It also offers faster treatment delivery times compared to traditional multi-room setups. This efficiency benefits both patients and healthcare providers, allowing for more streamlined scheduling and reduced waiting times.
 

The proton therapy systems market by application is categorized into breast cancer, lung cancer, prostate cancer, gastro-intestinal cancer, brain cancer, and others. The gastro-intestinal cancer segment accounted for USD 322 million revenue size in the year 2022. Globally, there were approximately 1.93 million cases reported in 2020 worldwide as it is the third most diagnosed cancer globally. Gastrointestinal cancers present a significant challenge in the realm of oncology, accounting for millions of new diagnoses and deaths annually. Traditional treatment approaches, including surgery, chemotherapy, and conventional radiation therapy, have been mainstays in combating these cancers.
 

However, the emergence of proton therapy has opened new avenues for more effective and less toxic treatments for gastrointestinal malignancies. In the context of GI cancers, where tumors are often located near critical structures such as the spinal cord, liver, or intestines, the ability to precisely target the tumor while minimizing damage to surrounding healthy tissues is of paramount importance. Proton therapy achieves this with unparalleled accuracy, reducing the risk of side effects and improving overall treatment outcomes.
 

Based on end-use, the proton therapy systems market is segmented into hospitals, proton therapy centers, and others. The hospitals segment accounted for 62% business share in the year 2022 and is anticipated to witness the highest growth during the forecast period. Hospitals, as the primary providers of cancer care, are key players in the growth and accessibility of proton therapy. Their recognition of the clinical benefits, commitment to patient-centered care, and role in research and innovation make them central to the expanding landscape of proton therapy.
 

Hospitals play a vital role in contributing to the scientific understanding of proton therapy's effectiveness through clinical research and data collection. As hospital demand continues to rise, the proton therapy market is poised to witness continued growth, offering hope and advanced treatment options to cancer patients worldwide. Therefore, patient convenience, higher R&D, advance technology are few factors that are estimated to remain at the forefront propelling the market for proton therapy systems.
 

U.S. proton therapy systems market accounted for USD 530 million revenue size in 2022 and is predicted to witness substantial market growth over the analysis timeline. The demand for proton therapy in the U.S. has been on a steady rise, driven by its clinical advantages, broader recognition, and investments in infrastructure and research. The U.S. market has seen the construction of new proton therapy centers and expansions of existing ones. Investments in these facilities demonstrate a commitment to meeting the rising demand for proton therapy. U.S. institutions have actively contributed to research and clinical trials related to proton therapy, furthering its clinical applications. As the American healthcare system continues to evolve, proton therapy's role in cancer treatment is anticipated to expand further, offering patients advanced and precise options in their fight against cancer.
 

Proton Therapy Systems Market Share

Some of the eminent market participants operating in the proton therapy systems market include

• IBA worldwide
• Hitachi
• Mevion Medical Systems
• Optivus Proton Therapy
• Advanced Oncotherapy plc
• Mitsubishi Electric Corporation
• Varian
• Ion Beam Applications SA
• ProTom International
• Provision Healthcar
• Sumitomo Heavy Industries, Ltd.

These market players are undertaking several growth strategies including partnerships, collaborations, acquisitions & mergers, new product development & launches to strengthen their product portfolio as well as gain a competitive edge over others.
 

Proton Therapy Systems Industry News:

• In December 2022, IBA won a contract for the installation of 10 proton therapy systems in Spain, which is being funded by the Amancio Ortega Foundation. The project is valued at over USD 229 million. The contract was signed with the Spanish Ministry of Health under a public-private partnership agreement. Such contract agreements strengthen the company’s position in the regional market.
   
• In October 2021, IBA launched a new interactive platform called Campus, which is dedicated to proton therapy. Campus is the world's first online proton therapy platform, and it is designed to provide a comprehensive and interactive learning experience for healthcare professionals, researchers, and patients. The launch of campus enhanced the accessibility and quality of proton therapy treatment and education, and it is considered as one of the significant developments in the field of proton therapy.
   

Proton therapy systems market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032 for the following segments:

Click here to Buy Section of this Report

By Set-up Type (USD Million)

• Single room
• Multiple room

By Indication (USD Million)

• Breast cancer
• Lung cancer
• Prostate cancer
• Gastro-intestinal cancer
• Brain cancer
• Others

By End-use (USD Million)

• Hospitals
• Proton therapy centers
• Others

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Switzerland
  • The Netherlands
  • Denmark
  • Poland
  • Sweden
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • New Zealand
  • Thailand
  • Vietnam
  • Indonesia
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Chile
• Middle East & Africa
  • Saudi Arabia
  • South Africa
  • UAE
  • Turkey